Paloma Partners’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-2,663
| Closed | -$260K | – | 1996 |
|
|
2021
Q1 | $260K | Sell |
2,663
-432
| -14% | -$42.2K | 0.01% | 1409 |
|
|
2020
Q4 | $238K | Sell |
3,095
-4,328
| -58% | -$333K | 0.01% | 1095 |
|
|
2020
Q3 | $547K | Sell |
7,423
-11,805
| -61% | -$870K | 0.01% | 968 |
|
|
2020
Q2 | $1.41M | Buy |
+19,228
| New | +$1.41M | 0.02% | 682 |
|
|
2020
Q1 | – | Sell |
-3,176
| Closed | -$249K | – | 1796 |
|
|
2019
Q4 | $249K | Sell |
3,176
-2,940
| -48% | -$230K | ﹤0.01% | 1569 |
|
|
2019
Q3 | $419K | Buy |
6,116
+2,470
| +68% | +$169K | 0.01% | 1009 |
|
|
2019
Q2 | $290K | Sell |
3,646
-2,895
| -44% | -$230K | ﹤0.01% | 1084 |
|
|
2019
Q1 | $549K | Buy |
6,541
+4,774
| +270% | +$401K | 0.01% | 726 |
|
|
2018
Q4 | $208K | Sell |
1,767
-2,400
| -58% | -$283K | 0.01% | 800 |
|
|
2018
Q3 | $502K | Buy |
4,167
+245
| +6% | +$29.5K | 0.01% | 766 |
|
|
2018
Q2 | $452K | Buy |
+3,922
| New | +$452K | 0.01% | 791 |
|
|
2016
Q2 | – | Sell |
-6,630
| Closed | -$403K | – | 1891 |
|
|
2016
Q1 | $403K | Sell |
6,630
-3,140
| -32% | -$191K | 0.01% | 1038 |
|
|
2015
Q4 | $624K | Buy |
9,770
+6,570
| +205% | +$420K | 0.02% | 626 |
|
|
2015
Q3 | $215K | Buy |
+3,200
| New | +$215K | 0.01% | 1121 |
|
|
2015
Q1 | – | Sell |
-4,150
| Closed | -$213K | – | 1305 |
|
|
2014
Q4 | $213K | Buy |
+4,150
| New | +$213K | 0.01% | 894 |
|